Myocytes respond to both interleukin-4 and interferon-γ: Cytokine responsiveness with the potential to influence the severity and course of experimental myasthenia gravis

Clinical Immunology

Volumn 94, Issue 2, 2000, Pages 133-139

  Stegall, Timothy ^a   Krolick, Keith A ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Cytokines; EAMG; IFN ; IL 15; IL 4; Muscle

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 15; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE SEVERITY; HISTOPATHOLOGY; IMMUNOMODULATION; IMMUNOPATHOGENESIS; MUSCLE CELL; MYASTHENIA GRAVIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT;

EID: 0033979257     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.1999.4822     Document Type: Article

References (50)

1. Patrick J., Lindstrom J. M. Autoimmune response to acetylcholine receptor. Science. 180:1973;871-872
2. Lindstrom J., Shelton D., Fujii Y. Myasthenia gravis. Adv. Immunol. 42:1988;233-284
3. Drachman D. B. Myasthenia gravis. N. Engl. J. Med. 330:1994;1797-1810
4. Toyka K., Drachman D., Pertronk A., Kao I. Myasthenia gravis: Passive transfer from man to mouse. Science. 190:1975;397-399
5. Lennon V., Lambert E. Myasthenia gravis induced by monoclonal antibodies to acetylcholine receptor. Nature. 285:1980;238-240
6. Gomez C., Richman D. Monoclonal anti-acetylcholine receptor antibodies with differing capacities to induce experimental autoimmune myasthenia gravis. J. Immunol. 135:1985;234-241
7. Tzartos S., Hochschwender S., Vasquez P., Lindstrom J. Passive transfer of experimental autoimmune myasthenia gravis by monoclonal antibodies to the main immunogenic region of the acetylcholine receptor. J. Neuroimmunol. 15:1987;185-194
8. Drachman D. B., Adams R. N., Josifek L. F., Self S. G. Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis. N. Engl. J. Med. 307:1982;769-775
9. Hohlfeld R., Sterz R., Kalies I., Wekerle H., Peper K. Experimental myasthenia: Lack of correlation between the autoantibody titer and the reduction of acetylcholine-controlled ionic channels measured at functioning endplates. Muscle Nerve. 6:1983;160-163
10. Lindstrom J., Seybold M. E., Lennon V. A., Whittingham S., Duane D. D. Antibody to acetylcholine receptor in myasthenia gravis: Prevalence, clinical correlates, and diagnostic value. Neurology. 26:1976;1054-1059
11. Tindall R. S. A. Humoral immunity in myasthenia gravis: Clinical correlations of anti-receptor antibody avidity and titer. Ann. N. Y. Acad. Science 377:1981;316-329
12. Olsberg C. A., Maxwell L. C., Mikiten T. M., Krolick K. A. Analysis of contractile properties of muscles from rats immunized with purified acetylcholine receptor. J. Neuroimmunol. 14:1987;253-266
13. Yeh T., Krolick K. A. Clonotypic analysis of anti-acetylcholine receptor antibodies produced against native and denatured antigen. J. Neuroimmunol. 24:1989;133-143
14. Zoda T., Yeh T. M., Krolick K. A. Clonotypic analysis of anti-acetylcholine receptor antibodies from EAMG-sensitive Lewis rats and EAMG-resistant Wistar Furth rats. J. Immunol. 146:1991;663-670
15. Thompson P. A., Krolick K. A. Acetylcholine receptor-reactive antibodies in experimental autoimmune myasthenia gravis differing in disease-causing potential: Subsetting by preparative isoelectric focusing. Clin. Immunol. Immunopathol. 62:1992;199-209
16. Krolick K. A., Thompson P. A., Zoda T. E., Mohan S., Yeh T-M. Experimental myasthenia gravis: Role of immunological fine-specificity. Hohlfeld R., Immunology of Neuromuscular Diseases. 1994;209-234 Kluwer Academic, Dordrecht, Norwell
17. Krolick K. A., Zoda T. E., Thompson P. A. Examination of characteristics that may distinguish disease-causing from benign AChR-reactive antibodies in experimental autoimmune myasthenia gravis. Adv. Neuroimmunol. 4:1994;475-493
18. Thompson P. A., Edlund S., Krolick K. A. Identification of an idiotype associated with antibodies responsible for neuromuscular dysfunction in rats with experimental autoimmune myasthenia-gravis. Clin. Immunol. Immunopathol. 75:1995;57-67
19. Krolick K. A., Yeh T-M., Edlund S. A. Lewis rats given antibodies against denatured acetylcholine receptor become resistant to induction of experimental autoimmune myasthenia gravis. Cell. Immunol. 172:1996;10-20
20. Balasa B., Deng C., Lee J., Bradley L. M., Dalton D. K., Christadoss P., Sarvetnick N. Interferon-γ (IFN-γ) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice. J. Exp. Med. 186:1997;385-391
21. Gu D., Wogensen L., Calcutt N. A., Xia C., Zhu S., Merlie J. P., Fox H. S., Lindstrom J., Powell H. C., Sarvetnick N. Myasthenia gravis-like syndrome induced by expression of interferon gamma in the neuromuscular junction. J. Exp. Med. 181:1995;547-557
22. Zhang G. X., Xiao B. G., Bai X. F., van der Meide P. H., Orn A., Link H. Mice with IFNγ receptor deficiency are less susceptible to experimental autoimmune myasthenia gravis. J. Immunol. 162:1999;3775-3787
23. Moiola L., Galbiati F., Nartino G., Amadio S., Brambilla E., Comi G., Vincent A., Grimaldi L., Adorini L. IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody-mediated disease. Eur. J. Immunol. 28:1998;2487-2497
24. Zhang G. X., Yu L. Y., Shi F. D., Xiao B. G., Bjork J., Hedlund G., Link H. Linomide suppresses both Th1 and Th2 cytokines in experimental autoimmune myasthenia gravis. J. Neuroimmunol. 73:1997;175-182
25. Wang Z. Y., Link H., Ljungdahl A., Hojeberg B., Link J., He B., Qiao J., Melms A., Olsson T. Induction of interferon-gamma, interleukin-4, and transforming growth factor-beta in rats orally tolerized against experimental autoimmune myasthenia gravis. Cell. Immunol. 157:1994;353-368
26. Ma C. G., Zhang G. X., Xiao B. G., Link H. Cellular mRNA expression of interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) in rats nasally tolerized against experimental autoimmune myasthenia gravis (EAMG). Clin. Exp. Immunol. 104:1996;509-516
27. + T cells suppresses the development of experimental autoimmune myasthenia gravis in Lewis rats. Eur. J. Immunol. 25:1995;1191-1198
28. Zhang G. X., Ma C. G., Xiao B. G., Bakhiet M., Ljungdahl A., Olsson T., Link H. Suppression of experimental autoimmune myasthenia gravis after CD8 depletion is associated with decreased IFN-gamma and IL-4. Scand. J. Immunol. 42:1995;457-465
29. + T cells are essential to induce experimental autoimmune myasthenia gravis. J. Exp. Med. 184:1996;349-356
30. Stegall T., Krolick K. A. A monoclonal Lewis rat myocyte line that responds to interferon-γ: Responsiveness with the potential to influence subsequent interactions with the immune system. Clin. Immunol. 94:1999;125-132
31. Shi F. D., Zhang G. X., Bai X. F., van der Meide P. H., Link H. Cellular mRNA expression of interferon-gamma (IFN-gamma), IL-4 and IL-10 relates to resistance to experimental autoimmune myasthenia gravis (EAMG) in young Lewis rats. Clin. Exp. Immunol. 108:1997;523-528
32. Giri, J. G., Anderson, D. M., Kumaki, S., Park, L. S., Grabstein, K. H., and Cosman, D., IL-15, a novel T cell growth factor that shares activities and receptor components with IL-2. J. Leukocyte Biol.57, 763-766, 1995. [Review]
33. Tagaya Y., Bamford R. N., DeFilippis P., Waldmann T. A. IL-15: A pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity. 4:1996;329-336
34. Grabstein K. H., Eisenman J., Shanebeck K., Rauch C., Srinivasan S., Fung V., Beers C., Richardson J., Schoenborn M. A., Ahdieh M., Johnson L., Alderson M. R., Watson J. D., Anderson D. M., Giri J. G. Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science. 264:1994;965-968
35. Blau H. M., Webster C. Isolation and characterization of human muscle cells. Proc. Natl. Acad. Science USA. 78:1981;6523-6528
36. Yaffe D. Retention of differentiation potentialities during prolonged cultivation of myogenic cells. Proc. Natl. Acad. Science USA. 61:1968;477-483
37. Krolick K. A., Urso O. E. Analysis of helper T cell function by acetylcholine receptor-reactive cell lines of defined AChR-subunit specificity. Cell. Immunol. 105:1987;75-85
38. Beauchamp J. R., Abraham D. J., Bou-Gharios G., Partridge T. A., Olsen I. Expression and function of heterotypic adhesion molecules during differentiation of human skeletal muscle in culture. J. Pathol. 140:1992;387-401
39. Michaelis D., Goebels N., Hohlfeld R. Constitutive and cytokine-induced expression of human leukocyte antigens and cell adhesion molecules by human myotubes. J. Pathol. 143:1993;1142-1149
40. Mantegazza R., Hughes S. M., Mitchell D., Travis M., Blau H. M., Steinman L. Modulation of MHC Class II antigen expression in human myoblasts after treatment with IFN-gamma. Neurology. 41:1991;1128-1132
41. Goebels N., Michaelis D., Wekerle H., Hohlfeld R. Human myoblasts as antigen presenting cells. J. Immunol. 149:1992;661-667
42. Mege R. M., Goudou D., Diaz G., Nicolet M., Garcia L., Geraud G., Rieger F. N-cadherin and N-CAM in myoblast fusion: Compared localization and effect of blockade by peptides and antibodies. J. Cell Science 103:1992;897-906
43. Bartoccioni E., Michaelis D., Hohlfeld R. Constitutive and cytokine-induced production of interleukin-6 by human myoblasts. Immunol. Lett. 42:1994;135-138
44. Lafyatis R., Lechleider R., Roberts A. B., Sporn M. B. Secretion and transcriptional regulation of transforming growth factor-beta 3 during myogenesis. Mol. Cell. Biol. 11:1991;3795-3803
45. Murwani R., Hodgkinson S., Armati P. Tumor necrosis factor α and interleukin-6 mRNA expression in neonatal Lewis rat Schwann cells and a neonatal rat Schwann cell line following interferon γ stimulation. J. Neuroimmunol. 71:1996;65-71
46. Zaheer A., Zhong W., Uc E. Y., Moser D. R., Lim R. Expression of mRNAs of multiple growth factors and receptors by astrocytes and glioma cells: Detection with reverse transcription-polymerase chain reaction. Cell. Mol. Neurobiol. 15:1995;221-237
47. Reinecker H.-C., MacDermott R. P., Mirau S., Dignass A., Podolsky D. K. Intestinal epithelial cells both express and respond to interleukin 15. Gastroenterology. 111:1996;1706-1713
48. Reyes-Reyna S. M., Krolick K. A. Chemokine production by rat myocytes exposed to interferon-γ Clin. Immunol. 94:1999;105-113
49. Mosmann T. R., Sad S. The expanding universe of T cell subsets: TH1, TH2 and more. Immunol. Today. 17:1996;138-146
50. Balasa B., Deng C., Lee J., Christadoss P., Sarvetnick N. The TH2 cytokine IL-4 is not required for the progression of antibody-dependent autoimmune myasthenia gravis. J. Immunol. 161:1998;2856-2862